A Novel Neutrophil-Based Biomarker to Monitor Disease Activity and Predict Response to Infliximab Therapy in Patients With Ulcerative Colitis

BACKGROUND: Ulcerative colitis (UC) is characterized by refractory and recurrent mucosal inflammation, leading to a substantial healthcare burden. Diagnostic biomarkers predicting disease activity and treatment response remain elusive. To evaluate the application value of a novel neutrophil-based in...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Zhou, Zhang, Yinghui, Pan, Yan, Yang, Xue, Li, Liangping, Gao, Caiping, He, Chong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092064/
https://www.ncbi.nlm.nih.gov/pubmed/35572985
http://dx.doi.org/10.3389/fmed.2022.872831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092064/
https://www.ncbi.nlm.nih.gov/pubmed/35572985
http://dx.doi.org/10.3389/fmed.2022.872831

Ejemplares similares